Abstract

The maximal proteolytic activity in plasma that can be obtained by activation with urokinase and in the presence of natural inhibitors is designated proteolytic capacity. A modified caseinolytic method measuring this parameter has been described. In a normal population large variations between individuals were found, and this is probably due to differences in the plasminogen-plasmin level. The caseinolytic method correlated well with in vitro thrombolysis and with fibrinogenolysis in plasma. Serum had a higher proteolytic capacity than plasma. Pregnancy and the oral contraceptives caused a pronounced rise in proteolytic capacity, whereas thyrotoxicosis caused a decrease in the capacity. Two healthy donors, one with zero proteolytic capacity and a plasminogen level of 35–45%, and one with very high proteolytic capacity and a plasminogen level of about 130% were studied in particular. No increased tendency for thrombosis was found in persons with very low or zero proteolytic capacity.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.